Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY

R. Hughes (Cambridge, United Kingdom), R. Del Olmo (Buenos Aires, Argentina), B. Make (Denver, CO, United States of America), D. Price (Aberdeen, United Kingdom), A. Agustí (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), J. Vestbo (Manchester, United Kingdom)

Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Session: New tools for risk stratification of obstructive diseases
Session type: Oral Presentation
Number: 3759
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Hughes (Cambridge, United Kingdom), R. Del Olmo (Buenos Aires, Argentina), B. Make (Denver, CO, United States of America), D. Price (Aberdeen, United Kingdom), A. Agustí (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), J. Vestbo (Manchester, United Kingdom). Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY. 3759

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019


Impact of severity on three spirometric definitions of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002

Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012


Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014

Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Factors associated with physician assessment of severity of asthma or COPD in NOVELTY
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020


Markers of T2-inflammation in patients with severe asthma and concomitant COPD
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001

Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020


Additional value of spirometry in risk assessment of acute respiratory disease in winter among patients with mild to moderate asthma or COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 473s
Year: 2002

Evaluation of the individual bronchodilator response in patients with severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials
Source: Eur Respir J 2006; 28: Suppl. 50, 175s
Year: 2006

Comparison of clinical characteristics between stable COPD patients with- and without mild bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 257s
Year: 2002

The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


Correlation between indices of quality of life and degree of severity of symptoms in patients with asthma in combination with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 520s
Year: 2004

COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

The relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012


Correlation between indices of quality of life and spirography in patients with asthma in combination with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 46s
Year: 2002